Hautarztpraxis Dr. Med. Matthias Hoffmann

The clinic in Witten is conducting research on palmoplantar pustulosis, a chronic skin disorder affecting the soles and palms. A study compares a new topical JAK inhibitor cream with a standard vehicle to determine its effectiveness in adult patients.

• Topical JAK inhibition as a novel approach
• Improvement in pain and lesion clearance
• Safety and tolerability during prolonged use

The goal is to offer a convenient, non‑systemic treatment option that can reduce symptoms and enhance daily functioning for those with mild to severe disease.

At Hautarztpraxis Dr. Med. Matthias Hoffmann, investigators are evaluating lebrikizumab, a biologic agent, for patients with nummular dermatitis whose condition is not adequately managed with topical corticosteroids.

• Targeting the interleukin‑13 pathway
• Efficacy in steroid‑refractory eczema
• Monitoring long‑term safety outcomes

This research aims to broaden therapeutic choices and improve skin health for individuals struggling with persistent, itchy patches.